SciFi Futures
← Capabilities
Biotech & Medicine/Component technology

Weeks-long extracorporeal blood oxygenation

Membrane oxygenator circuits that exchange gas with flowing blood for weeks without clotting, hemolysis or heavy anticoagulation.

State of the art

Clinical ECMO supports adults and neonates for weeks; pumpless low-resistance umbilical oxygenator circuits sustained fetal lambs for up to four weeks (CHOP EXTEND data presented to FDA, 2023).

What’s blocking it
  • Blood-surface contact activates coagulation, so runs depend on anticoagulation that causes bleeding in fragile patients
  • Oxygenator plasma leakage and fiber fouling limit single-circuit life
  • Hemolysis and platelet consumption scale with pump shear and circuit length

Who’s working on it

  • Alan FlakeResearcher
    Children's Hospital of Philadelphia

    Built the EXTEND extrauterine support system and is a named inventor on CHOP and Vitara pumpless neonatal oxygenator filings published in 2026

  • Vitara BiomedicalStartup

    CHOP spin-out that raised a 50 million dollar Series B in November 2024 (Sands Capital, GV, Khosla) to take its oxygenation circuit to first-in-human

  • George MychaliskaResearcher
    University of Michigan

    Lead author on the nitric-oxide surface anticoagulation circuit that supported premature lambs for a week with no systemic anticoagulant (Pediatric Research, 2023)

  • Robert BartlettResearcher
    University of Michigan

    Founder of clinical ECMO; his group's decades of artificial-placenta work underpin the current heparin-free circuit designs

  • GetingeCompany

    Maker of the Cardiohelp and Cardiosave systems; in 2025 it ended surgical perfusion production to reallocate R and D into ECMO and transplant care

  • MedtronicCompany

    Launched the all-in-one VitalFlow ECMO system in September 2024, adding competition in the US extracorporeal support market

  • EurosetsCompany

    Sells heparin-free phosphorylcholine-coated A.L.ONE oxygenator modules rated for 30-day ECMO runs in adults, children and newborns

What to invest in

KindInvestmentScale
researchTruly non-thrombogenic surface coatings validated over multi-week large-animal runs without systemic heparin$$ $10M – $100M
engineeringMiniaturized low-prime pumpless oxygenators sized for sub-kilogram patients$$ $10M – $100M

Sci-fi concepts in reach

Resurrection of extinct speciesindirectHeaven (permanent virtual retreat)directAI cybrid (AI persona in a grown human body)indirectIndustrial ectogenesis (hatcheries)indirectNexus-6 androids (replicants)indirectResleeving (transferring a mind into a new body)indirect

Sources